Early value dossiers for medical technologies
The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders
Recent news and posts
Publications Digest: Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest.
In a recent publication, Horgan et al. completed a survey of the status of Next-Generation Sequencing (NGS) in Europe and globally.
Based on the feedback from 62 experts, a framework for implementation of the NGS is proposed along with in-depth discussion about current aspects of demand-and supply-side issues, governance and strategy, clinical standardization, awareness and education, equipment used, reimbursement, and funding.
Access the full text article here.